VAN ECK VIP Emerging Markets Fund has bought 21.26 lakh shares of Marksans Pharma through the open market route. The shares were purchased on an average price of Rs 61.39 valuing the transaction to Rs 13.05 crore.
Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.